The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones

PURPOSE

To evaluate the impact of a ureteral access sheath (UAS) on stone-free (SF) rate after flexible ureteroscopy for upper urinary tract stones.

MATERIALS AND METHODS

We retrospectively reviewed 280 patients who underwent flexible ureteroscopy (URS) for upper urinary tract stone between 2009 and 2012. Patients were divided into two groups based on whether a UAS was used (n = 157) or not (n = 123). SF rate was evaluated at one and three months after surgery by abdominal imaging. Quantitative and qualitative variables were compared with Student's t test and χ2 test, respectively. A logistic regression model was used to determine the predictive factors of SF status.

RESULTS

Stone size was similar in both groups (15.1 vs. 13.7 mm, p = 0.21). SF rates at one and 3 months were comparable in UAS and non-UAS groups (76 vs. 78% and 86 vs. 87%, p = 0.88 and 0.89, respectively). Complication rates were similar in both groups (12.7 vs. 12.1%, p = 0.78). In multivariable analysis, stone size was the only predictive factor of SF rate (p = 0.016).

CONCLUSION

The routine use of a UAS did not improve SF rate in patients undergoing flexible URS for upper urinary tract calculi.

[Erdheim-Chester disease: report of a case and literature review]

The Erdheim-Chester disease is a rare non-Langerhans hystiocytose acquired in adults. It results from a xanthogranulomatous infiltration, consists of histioccytes foamy and is characterized by heterogeneous systemic manifestations. The most frequent clinical manifestations of the disease are the bone with a long bone uptake on bone scintigraphy99Tc (Dion et al., 2006) and urological damage with an array of pseudo retroperitoneal fibrosis. We report the case of a 64-year-old man in whom was founded in the course of acute obstructive renal disease with Erdheim-Chester pseudofibrose retroperitoneal.